iCardio.ai
iCardio.ai35
About
No comments yet. Be the first to share your take.
What does iCardio.ai do?
iCardio.ai develops AI-powered solutions to automate echocardiographic analysis, including EchoMeasure™ for automated echo measurements and CardioVision™ for auto-detecting aortic stenosis. They partner with ultrasound companies to deliver their technology to clinicians and enterprises, aiming to integrate AI into cardiac imaging pipelines. The company also offers data for projects and expert interpretations assisted by AI.
Where is iCardio.ai headquartered?
iCardio.ai is headquartered in Tel Aviv, Israel.
When was iCardio.ai founded?
iCardio.ai was founded in 2019.
What industry does iCardio.ai operate in?
iCardio.ai operates in Healthcare, Ultrasound, Medical Imaging, HealthTech, MedTech, AI-Driven Protein Design.
How many employees does iCardio.ai have?
iCardio.ai has approximately 19 people on record.
What is iCardio.ai's revenue?
StartupHub estimates iCardio.ai's annual revenue at $5.7M (range $3.3M to $10.6M, 63% confidence), based on comparable companies in the sector.